How the way doctors explain epidural steroid injections affects sciatica pain outcomes
Official title: PEACE Study: Psychophysical Enhancement to Augment Conservative and Epidural Steroid Injection Outcomes: A Multi-Center International Randomized Trial
Run by Northwestern University · NCT07498140 · Data updated 2026-11-12
This trial will test whether explaining epidural steroid injections more positively or more neutrally changes pain for adults with lumbosacral radiculopathy who are candidates for injections.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 210 (estimated) |
| Sponsor | Northwestern University Academic / other |
| Locations | 4 sites (Chicago, Illinois and 3 other locations) |
| Status | Recruiting |
| Started | March 30, 2026 |
| Main results expected | March 25, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07498140 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with MRI-confirmed lumbosacral radiculopathy for more than 6 weeks, moderate-to-severe leg pain, and who are candidates for epidural steroid injection or pharmacotherapy are ideal.
✕Probably not a fit
Patients with prior spine surgery, recent epidural steroid injection (within 2 years), very long-standing leg pain (>15 years), untreated coagulopathy, signs of cauda equina syndrome, allergies or contraindications to contrast or the study medications, or prior failure of key neuropathic pain drugs are excluded and unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Two hundred ten adults with MRI-confirmed lumbosacral radiculopathy and moderate-to-severe leg pain will be randomized in a 2:2:1 ratio to positive framing for epidural steroid injection (ESI), neutral framing for ESI, or a pharmacotherapy plus exercise active control. Randomization is blocked in groups of 10 and suballocated by unilateral versus bilateral symptoms to match injection type (transforaminal vs interlaminar). The positive framing arm receives a brief slide presentation summarizing evidence and guidelines that present ESI more favorably, while the neutral arm receives more neutral information; an investigator is available to answer questions. Pain and related outcome measures will be compared across groups to see whether expectation framing changes the effectiveness of ESI.
Why it matters
Potential benefit: If successful, changing how clinicians present epidural injections could reduce pain and improve function without altering the procedure or medications.
How similar studies have gone: Prior research shows strong placebo and expectation effects for pain treatments and some evidence that procedural framing can influence outcomes, but randomized trials specifically testing framing for epidural steroid injections are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 * Lumbosacral radicular pain based on history and physical exam (e.g. pain radiating into one or both lower extremities, sensory loss, muscle weakness, positive straight leg raising test etc.) * Duration of pain \>6 weeks * NRS leg pain score \>/= 4 (or if 3/10, greater or equal to back pain \& worst leg pain is \>/=4) * MRI evidence of spinal pathology consistent with symptoms * Candidates for ESI and pharmacotherapy Exclusion Criteria: * Untreated coagulopathy * Previous spine surgery * No MRI or non-concordant MRI study * Leg pain \> 15 years duration * Epidural steroid injection within past 2 years * Signs or symptoms of cauda equina syndrome * Previous failed trials with gabapentin and pregabalin and tricyclic antidepressants and duloxetine * Allergic reactions to contrast dye prohibiting injection (e.g., tranforaminal ESI), gabapentinoids, tricyclic antidepressants or duloxetine, and contraindications to all of the above medications * Referrals from surgery for diagnostic injections for surgical evaluation * Serious medical (e.g. congestive heart failure) or psychiatric (untreated depression) condition that might preclude optimal outcome * Pregnancy * Inability to understand basic English
Where it's running
-
Northwestern University
Chicago, Illinois, United States Recruiting -
Phramongkutklao Military Hospital
Bangkok, Thailand Recruiting -
Walter Reed National Military Medical Center
Bethesda, Maryland, United States Enrolling by invitation -
First Lviv Medical Union
Lviv, Ukraine Not yet recruiting
Study contacts
- Principal investigator: Steven P Cohen, MD — Northwestern University
- Study coordinator: Steven P Cohen, MD
- Email: steven.cohen@northwestern.edu
- Phone: 312-695-2500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TFESI for neuropathic pain in lumbosacral radiculopathy
This study tests whether a transforaminal epidural steroid injection relieves neuropathic pain in adults with lumbosacral radiculopathy.
-
Three CT Signs of Nerve-Root Suffering in Low-Back Sciatica: How Often They Occur in Patients Referred for CT-Guided Nerve-Root Infiltration
This study tests whether three specific CT signs align with the nerve root causing symptoms in adults with low-back sciatica who are scheduled for CT-guided nerve-root infiltration.
-
Ultrasound-guided vs fluoroscopy-guided lumbar nerve injections for leg/back pain
In adults with leg and lower back nerve pain, this study tests whether ultrasound guidance works as well as traditional X-ray guidance for lumbar nerve root injections.
-
Safety of a single transforaminal C-1101 injection versus saline for chronic sciatica
This will test whether a single transforaminal epidural injection of C-1101 is safe and well tolerated compared with sterile saline in adults with chronic sciatica who have not improved with conservative care.
-
Move-MORE: Online mindfulness, gentle movement, and motivational coaching for lumbosacral radiculopathy
This project tests whether an online program of mindfulness, gentle movement, and motivational interviewing can help adults with chronic lumbosacral radiculopathy (sciatica) reduce pain, improve function, and increase daily activity.
-
VER-01 for chronic painful lumbosacral radiculopathy
This phase 3 trial tests VER-01 against placebo to see if it can reduce pain in adults with chronic painful lumbosacral radiculopathy who have not found sufficient relief with non-opioid medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.